Stephan Strass


About Stephan Strass
Stephan advises innovative start-ups, institutional and strategic investors and other companies on acquisitions, financing rounds, joint ventures and exit transactions with a focus on highly regulated industries such as life sciences, biotech and leisure & entertainment. He further specializes in commercial transactions in the life science and biotech sector, including university spin-offs, strategic collaborations, patent and technology license agreements and IP purchase transactions.

He has co-authored commentaries on the EU Merger Act and the Investment Fund Act, and is the author of many academic publications.

University of Vienna, Faculty of Law (Mag. iur. 2015)
Harvard Law School, Master of Laws (LL.M. 2019)
» Stephan Strass already has an outstanding market reputation and leads a broad range of M&A projects for a variety of clients mainly from the tech sector. Stephan is very hands-on, extremely experienced and always available. He has a dedicated focus on the life sciences and biotech sector and advises many clients also on commercial transactions. Stephan is, without any doubt, one of the few rising stars in the Austrian M&A market. «
Legal 500
Working highlights
Advising the shareholders of Allcyte on the sale to Exscientia
Advising the seller consortium, including Farallon, Global Health Investment Fund, Wellington Partners and Ventech on the sale of Themis to Merck Sharp Dohme
Advising numerous start-ups and other companies in the life sciences sector on university spin-offs and technology transactions
Advising Sportradar on its initial public offering on NASDAQ
Advising AC Immune on the acquisition of a vaccine candidate against Parkinson's disease (Affiris)